Clinical Trial

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This is a long-term safety study to evaluate the safety and tolerability of intermittent use of elismetrep in the acute treatment of migraine attacks.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-08-07
notable Trial sites reduced: 120 -> 115 locations 2026-07-03
Trial Details
NCT Number NCT07674654
Lead Sponsor Kallyope Inc.
Conditions Acute Migraine
Enrollment 1,000 participants
Start Date 2026-08-03
Primary Completion 2028-06 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2026-08-12